Codexis, Inc. completed a public offering of 16,666,677 shares of common stock at $1.50 per share, generating approximately $23.1 million in net proceeds. The offering was underwritten by Piper Sandler & Co. and Cantor Fitzgerald & Co. as representatives. Codexis, Inc. is a biotechnology company that develops enzyme-based solutions for industrial and pharmaceutical applications.
